New: Biosimilars strategies introduced.
Close
Valuable and timely information on drug therapy issues impacting today's health care and pharmacy environment.
December 14, 2022 - The FDA approved new indications and updates to the current indications for Genentech’s Xeloda (capecitabine).
Download PDF
Return to publications
